
News|Articles|October 1, 2005
PREAMI trial
The ACE inhibitor perindopril significantly reduced left ventricular remodeling in a well-treated population of older patients with acute myocardial infarction (MI) and preserved ejection fraction, said Roberto Ferrari, MD, PhD, lead investigator of the Perindopril Remodeling in Elderly with Acute Myocardial Infarction (PREAMI).
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
3 things to know about CVS Health’s 2025 earnings
3
IRA price reductions to have little impact on future innovation, analysis finds
4
A conversation about the consequences of Florida’s HIV medication cuts with Colleen Kelley, M.D., M.P.H., immediate past chair of the HIVMA and HIV specialist in Atlanta, Georgia
5

























